Who would want to take over this company? 20 years of trials and all MM can say is the drug keeps showing "interesting things" while admitting there are no assays available to prove this drug does anything to clear out reservoirs in HIV.... while Stephen Becker could not be anymore unenthusiastic during webinar when he pronounced the HIV trials were NOT a home run. If you can't prove up a drug over 20 years with multiple Phase II trials then it is dead.
CRO's have been doing work exclusively for 2 years + on these trials.... every time MM has made statements recently the blame has been pointed elsewhere.... it's all too hard, it's COVID's fault, The Thai government, there are no available assays, CRO's create frustrating delays etc..... However I would like to know how MM spends her time to justify the near $1 million in salaries collected during the last 2 years while CRO's have been doing analysis? You don't get the big bickies by pointing the figure at everyone else but yourself... Both tax payors and shareholders funds which need to be justified over 20 years to delivery a share price of 1.7 cents.
Last 2 years there has been NO announcement of any new project, NO movement on the promised Hepatitis B Program, NO attendance at any significant networking events regarding HIV or COVID, NO presentations to scientific communities, NO communication to shareholders, NO strategy regarding future funding & management of existing funds, NO leads on any other compounds. The only thing that seems to have been finished are the never ending WIP knitting jobs posted on Instagram while working from home.
BIT Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
